Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ).
Hansoh Pharmaceutical Group Company Limited announced a final cash dividend of HKD 0.1353 per share for the year ending December 31, 2024. The dividend reflects the company’s financial performance and commitment to providing returns to its shareholders. The ex-dividend date is set for July 3, 2025, with payment scheduled for July 25, 2025. This announcement may positively impact the company’s market positioning by reinforcing investor confidence and showcasing its financial health.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited operates in the pharmaceutical industry, focusing on the development, production, and marketing of innovative drugs. The company is known for its efforts in advancing treatments in areas such as oncology, central nervous system disorders, and infectious diseases.
YTD Price Performance: 21.82%
Average Trading Volume: 6,198,327
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$117.5B
For detailed information about 3692 stock, go to TipRanks’ Stock Analysis page.